How To Determine The Severity Of Concussions.
A unfamiliar eye-tracking avenue might help determine the severity of concussions, researchers report. They said the green approach can be used in emergency departments and, perhaps one day, on the sidelines at sporting events. "Concussion is a prepare that has been plagued by the lack of an objective diagnostic tool, which in turn has helped hustle confusion and fears among those affected and their families," said lead investigator Dr Uzma Samadani vigrx ytd. She is an aide-de-camp professor in the departments of neurosurgery, neuroscience and physiology at NYU Langone Medical Center in New York City.
So "Our budding eye-tracking methodology may be the missing fraction to help better diagnose concussion severity, enable testing of diagnostics and therapeutics, and succour assess recovery, such as when a patient can safely return to work following a head injury," she explained in an NYU scuttlebutt release more. According to researchers, it's believed that up to 90 percent of patients with concussions or gale injuries have eye movement problems.
Showing posts with label patient. Show all posts
Showing posts with label patient. Show all posts
Wednesday 22 May 2019
Thursday 17 January 2019
Computer Simulation Of The New Look Of The Nose
Computer Simulation Of The New Look Of The Nose.
Computer imaging software gives patients a sort of favourable idea of how they'll look after a "nose job," and the the greater part value the preview process, a new study finds. The "morphing" software, employed by plastic surgeons since the 1990s, appears to improve patient-doctor communication, surgeons active with the study said. "Having an image of an individual in front of you and manipulating that nose on the television is better than the patient showing me pictures of 15 other women's noses she likes," said Dr Andrew Frankel, elder study author and a plastic surgeon at the Lasky Clinic in Beverly Hills, Calif source. "It's her kisser and her nose".
Patients who thought their computer image was accurate tended to be happier about the results, the about found, while plastic surgeons were less likely than patients to think the computer archetype correctly predicted how the remodeled nose turned out vigrxbox.com. The study is in the November/December daughter of the Archives of Facial Plastic Surgery.
The imaging software was a major step forward in the epoch of rhinoplasty, or plastic surgery of the nose. "Before computer imaging, people would bring in pictures of celebrities or other noses they liked and would say, 'Could you make it with me look like this?'" Frankel said.
But propitious that was often impossible, plastic surgeons said. Plastic surgeons can break bone, scrape off or reshape the cartilage that makes up the lower two-thirds of the nose, even graft cartilage from other areas of the body onto the nose, but they are still fixed by the nose's basic structure.
And "I have to constantly communicate to the patient what are within reason expectations," said Dr Richard Fleming, a Beverly Hills plastic surgeon. "If VIP comes in with a huge Roman nose and they want a little turned up pug nose, you're not affluent to give it to them. It cannot be accomplished".
And even nearly identical noses will look different on different people. "Everything else about the lineaments structure and the person could be different - the skin color, eyes, summit - there is no translation between some Latina celebrity's nose and some Irish 40-year-old's nose".
Computer imaging software gives patients a sort of favourable idea of how they'll look after a "nose job," and the the greater part value the preview process, a new study finds. The "morphing" software, employed by plastic surgeons since the 1990s, appears to improve patient-doctor communication, surgeons active with the study said. "Having an image of an individual in front of you and manipulating that nose on the television is better than the patient showing me pictures of 15 other women's noses she likes," said Dr Andrew Frankel, elder study author and a plastic surgeon at the Lasky Clinic in Beverly Hills, Calif source. "It's her kisser and her nose".
Patients who thought their computer image was accurate tended to be happier about the results, the about found, while plastic surgeons were less likely than patients to think the computer archetype correctly predicted how the remodeled nose turned out vigrxbox.com. The study is in the November/December daughter of the Archives of Facial Plastic Surgery.
The imaging software was a major step forward in the epoch of rhinoplasty, or plastic surgery of the nose. "Before computer imaging, people would bring in pictures of celebrities or other noses they liked and would say, 'Could you make it with me look like this?'" Frankel said.
But propitious that was often impossible, plastic surgeons said. Plastic surgeons can break bone, scrape off or reshape the cartilage that makes up the lower two-thirds of the nose, even graft cartilage from other areas of the body onto the nose, but they are still fixed by the nose's basic structure.
And "I have to constantly communicate to the patient what are within reason expectations," said Dr Richard Fleming, a Beverly Hills plastic surgeon. "If VIP comes in with a huge Roman nose and they want a little turned up pug nose, you're not affluent to give it to them. It cannot be accomplished".
And even nearly identical noses will look different on different people. "Everything else about the lineaments structure and the person could be different - the skin color, eyes, summit - there is no translation between some Latina celebrity's nose and some Irish 40-year-old's nose".
Monday 24 December 2018
The New Role Of Stem Cells For Treatment Of Neoplastic Diseases
The New Role Of Stem Cells For Treatment Of Neoplastic Diseases.
For wise myeloid leukemia patients, overactive genes in their leukemic staunch cells (LSC) can forward into a more difficult struggle to overcome their disease and achieve prolonged remission, unknown research reveals. "In many cancers, specific subpopulations of cells appear to be uniquely efficient of initiating and maintaining tumors," the study authors explained in their report barbati. The researchers identified 52 LSC genes that, when strongly active, appear to prompt worse outcomes to each acute myeloid leukemia (AML) patients.
The finding is reported in the Dec 22/29 2010 discharge of the Journal of the American Medical Association. Between 2005 and 2007, con author Andrew J Gentles, of Stanford University in Palo Alto, California, and colleagues examined gene motion in a group of AML patients as well as healthy individuals visit your url. Separate details concerning AML tumors in four groups of patients (totaling more than 1000) was also analyzed.
In one of the tireless groups, the investigators found that higher activity levels among 52 LSC genes meant a 78 percent peril of death within a three-year period. This compared with a 57 percent imperil of death in the same time frame for AML patients with lower gene activity amongst these specific "signature" genes. In another AML patient group, the research team observed that higher gene work prompted an 81 percent risk for experiencing a disease impediment over three years, compared with just a 48 percent risk among patients with low gene activity.
What's more, Gentles and his colleagues found that higher undertaking among these 52 LSC genes in a general way meant a poorer response to chemotherapy treatment and lower remission rates. The authors suggested that by "scoring" the vigour levels of these 52 genes from low to high, clinicians might be able to better forecast how well AML patients will respond to therapy.
For wise myeloid leukemia patients, overactive genes in their leukemic staunch cells (LSC) can forward into a more difficult struggle to overcome their disease and achieve prolonged remission, unknown research reveals. "In many cancers, specific subpopulations of cells appear to be uniquely efficient of initiating and maintaining tumors," the study authors explained in their report barbati. The researchers identified 52 LSC genes that, when strongly active, appear to prompt worse outcomes to each acute myeloid leukemia (AML) patients.
The finding is reported in the Dec 22/29 2010 discharge of the Journal of the American Medical Association. Between 2005 and 2007, con author Andrew J Gentles, of Stanford University in Palo Alto, California, and colleagues examined gene motion in a group of AML patients as well as healthy individuals visit your url. Separate details concerning AML tumors in four groups of patients (totaling more than 1000) was also analyzed.
In one of the tireless groups, the investigators found that higher activity levels among 52 LSC genes meant a 78 percent peril of death within a three-year period. This compared with a 57 percent imperil of death in the same time frame for AML patients with lower gene activity amongst these specific "signature" genes. In another AML patient group, the research team observed that higher gene work prompted an 81 percent risk for experiencing a disease impediment over three years, compared with just a 48 percent risk among patients with low gene activity.
What's more, Gentles and his colleagues found that higher undertaking among these 52 LSC genes in a general way meant a poorer response to chemotherapy treatment and lower remission rates. The authors suggested that by "scoring" the vigour levels of these 52 genes from low to high, clinicians might be able to better forecast how well AML patients will respond to therapy.
Friday 16 November 2018
Cell Phones To Remotely Control Your Blood Pressure
Cell Phones To Remotely Control Your Blood Pressure.
Diabetics may soon awaken that backing in controlling their blood pressure is just a cell phone screen away. Researchers are now exploring the hidden of a new mobile phone monitoring system that automatically picks up patients' residency blood pressure readings, which is then sent out wirelessly via radio signals from monitoring furnishings outfitted with Blue-tooth technology testmedplus.com. The cell phones are pre-programmed to transmit the blood put the screws on readings and receive appropriate feedback (which appear instantly on the cell phone screen).
Good readings may awaken a message of "Congratulations," while problematic results may trigger a message advising the patients to pressure a check-up appointment with their doctor click for source. The interactive system may also instruct patients to opt for more readings over a specified period of time to get a more reliable overall reading.
What's more, if any two-week or three-day years exceeds a pre-set average reading threshold, the patient's doctor would be automatically notified. In addition, doctors would be able to log online to arrest their patient's readings. Dr Alexander G Logan, from the University of Toronto, is slated to consult on the experimental monitoring system Wednesday at the American Heart Association annual conjunction in Chicago.
One expert said the technology can provide a valuable service. "Telemonitoring provides info regarding a patient's progress and condition between physician visits, and assists clinicians in identifying patients who have antiquated symptoms of a more serious condition that, if sinistral untreated, may require acute care, like hospitalization," explained Dr Peter Rutherford, medical cicerone at Wenatchee Valley Medical Center in Wenatchee, Wash. "In the end the patient's commitment in the program, coupled with the case manager's involvement in the patient's care and the physician's practice, is a alive piece of the disease management puzzle".
Diabetics may soon awaken that backing in controlling their blood pressure is just a cell phone screen away. Researchers are now exploring the hidden of a new mobile phone monitoring system that automatically picks up patients' residency blood pressure readings, which is then sent out wirelessly via radio signals from monitoring furnishings outfitted with Blue-tooth technology testmedplus.com. The cell phones are pre-programmed to transmit the blood put the screws on readings and receive appropriate feedback (which appear instantly on the cell phone screen).
Good readings may awaken a message of "Congratulations," while problematic results may trigger a message advising the patients to pressure a check-up appointment with their doctor click for source. The interactive system may also instruct patients to opt for more readings over a specified period of time to get a more reliable overall reading.
What's more, if any two-week or three-day years exceeds a pre-set average reading threshold, the patient's doctor would be automatically notified. In addition, doctors would be able to log online to arrest their patient's readings. Dr Alexander G Logan, from the University of Toronto, is slated to consult on the experimental monitoring system Wednesday at the American Heart Association annual conjunction in Chicago.
One expert said the technology can provide a valuable service. "Telemonitoring provides info regarding a patient's progress and condition between physician visits, and assists clinicians in identifying patients who have antiquated symptoms of a more serious condition that, if sinistral untreated, may require acute care, like hospitalization," explained Dr Peter Rutherford, medical cicerone at Wenatchee Valley Medical Center in Wenatchee, Wash. "In the end the patient's commitment in the program, coupled with the case manager's involvement in the patient's care and the physician's practice, is a alive piece of the disease management puzzle".
Wednesday 13 December 2017
Patients More Easily Tolerate Rheumatoid Arthritis In A Good Marriage
Patients More Easily Tolerate Rheumatoid Arthritis In A Good Marriage.
A opportune merger helps people with rheumatoid arthritis enjoy better nobility of life and experience less pain, a new study suggests. "There's something about being in a high-quality federation that seems to buffer a patient's emotional health," said research leader Jennifer Barsky Reese, a postdoctoral kid at the Johns Hopkins University School of Medicine in Baltimore herbaltor.men. But RA patients in distressed marriages were no better off in terms of attribute of life and pain than the unmarried patients she studied.
The story is published in the October issue of The Journal of Pain. Reese said her bone up went further than other research that has linked being married to aspects of better health hidden camera womens ting. "What we did was look at both marital pre-eminence and how the quality of the marriage is related to different health status measures in the patient," such as their perception of tribulation and physical and psychological disability.
The researchers evaluated 255 adults with RA, a painful and potentially debilitating system of arthritis, for marital adjustment, disease activity and pain. Forty-four were in distressed marriages, 114 not distressed and 97 were unmarried. Their typical age was 55.
The participants answered questions about how felicitous they were in their marriage, and also noted how much they agreed or disagreed in key areas, including finances, demonstrations of affection, sex, rationalism of life and interaction with in-laws. "Before we controlled for anything such as illness severity, being in a high-quality marriage is associated with better outcome. These findings suggest the links between being married and trim depend on the quality of the marriage, not simply whether or not one is married".
When the researchers took into reckoning such factors as age and disease severity, they found that "better marital quality is still related to lower affective sadden and lower psychological disability". Affective pain is an emotional evaluation of pain, how unpleasant a lenient finds it. Another measure, sensory pain, reflects how the pain is perceived, how it feels physically to the patient.
A opportune merger helps people with rheumatoid arthritis enjoy better nobility of life and experience less pain, a new study suggests. "There's something about being in a high-quality federation that seems to buffer a patient's emotional health," said research leader Jennifer Barsky Reese, a postdoctoral kid at the Johns Hopkins University School of Medicine in Baltimore herbaltor.men. But RA patients in distressed marriages were no better off in terms of attribute of life and pain than the unmarried patients she studied.
The story is published in the October issue of The Journal of Pain. Reese said her bone up went further than other research that has linked being married to aspects of better health hidden camera womens ting. "What we did was look at both marital pre-eminence and how the quality of the marriage is related to different health status measures in the patient," such as their perception of tribulation and physical and psychological disability.
The researchers evaluated 255 adults with RA, a painful and potentially debilitating system of arthritis, for marital adjustment, disease activity and pain. Forty-four were in distressed marriages, 114 not distressed and 97 were unmarried. Their typical age was 55.
The participants answered questions about how felicitous they were in their marriage, and also noted how much they agreed or disagreed in key areas, including finances, demonstrations of affection, sex, rationalism of life and interaction with in-laws. "Before we controlled for anything such as illness severity, being in a high-quality marriage is associated with better outcome. These findings suggest the links between being married and trim depend on the quality of the marriage, not simply whether or not one is married".
When the researchers took into reckoning such factors as age and disease severity, they found that "better marital quality is still related to lower affective sadden and lower psychological disability". Affective pain is an emotional evaluation of pain, how unpleasant a lenient finds it. Another measure, sensory pain, reflects how the pain is perceived, how it feels physically to the patient.
Saturday 30 September 2017
Women Suffer From Rheumatoid Arthritis More Often Than Men
Women Suffer From Rheumatoid Arthritis More Often Than Men.
Rheumatoid arthritis patients can on average face forward to a much better quality of life today than they did 20 years ago, immature research suggests. The observation is based on a comparative multi-year tracking of more than 1100 rheumatoid arthritis patients. All had been diagnosed with the often savagely debilitating autoimmune infirmity at some point between 1990 and 2011 startvigrx.top. The reason for the brighter outlook: a combination of better drugs, better effect and mental health therapies, and a greater effort by clinicians to boost patient spirits while encouraging continued earthly activity.
And "Nowadays, besides research on new drug treatments, digging is mainly focused on examining which treatment works best for which patient, so therapy can become more 'tailor-made' and therefore be more effective for the special patient," said Cecile Overman, the study's lead author. Overman, a doctoral evaluator in clinical and health psychology at Utrecht University in the Netherlands, expects that in another 20 years, rheumatoid arthritis patients will have the same eminence of life as anyone else "if the focus on the whole patient - not just the disease, but also the person's psychotic and physical well-being - is maintained and treatment opportunities continue to evolve thyroid. The contemplate was released online Dec 3, 2013 in Arthritis Care and Research.
In rheumatoid arthritis, the body's unsusceptible system mistakenly attacks the joints, the Arthritis Foundation explains. The resulting swelling can damage joints and organs such as the heart. Patients knowledge sudden flare-ups with warm, swollen joints, pain and fatigue. Currently there is no cure but a multifariousness of drugs can treat symptoms and prevent the condition from getting worse.
Up to 1 percent of the world's people currently struggles with the condition, according to the World Health Organization. The current study was composed basically of female rheumatoid arthritis patients (68 percent). Women are more prone to developing the outfit than men. Patients ranged in age from 17 to 86, and all were Dutch.
Each was monitored for the dawn of disease-related physical and mental health disabilities for anywhere from three to five years following their approve diagnosis. Disease activity was also tracked to assess progression. The observed trend: a major two-decade drop in physical disabilities. The researchers also saw a decline in the incidence of worry and depression.
Rheumatoid arthritis patients can on average face forward to a much better quality of life today than they did 20 years ago, immature research suggests. The observation is based on a comparative multi-year tracking of more than 1100 rheumatoid arthritis patients. All had been diagnosed with the often savagely debilitating autoimmune infirmity at some point between 1990 and 2011 startvigrx.top. The reason for the brighter outlook: a combination of better drugs, better effect and mental health therapies, and a greater effort by clinicians to boost patient spirits while encouraging continued earthly activity.
And "Nowadays, besides research on new drug treatments, digging is mainly focused on examining which treatment works best for which patient, so therapy can become more 'tailor-made' and therefore be more effective for the special patient," said Cecile Overman, the study's lead author. Overman, a doctoral evaluator in clinical and health psychology at Utrecht University in the Netherlands, expects that in another 20 years, rheumatoid arthritis patients will have the same eminence of life as anyone else "if the focus on the whole patient - not just the disease, but also the person's psychotic and physical well-being - is maintained and treatment opportunities continue to evolve thyroid. The contemplate was released online Dec 3, 2013 in Arthritis Care and Research.
In rheumatoid arthritis, the body's unsusceptible system mistakenly attacks the joints, the Arthritis Foundation explains. The resulting swelling can damage joints and organs such as the heart. Patients knowledge sudden flare-ups with warm, swollen joints, pain and fatigue. Currently there is no cure but a multifariousness of drugs can treat symptoms and prevent the condition from getting worse.
Up to 1 percent of the world's people currently struggles with the condition, according to the World Health Organization. The current study was composed basically of female rheumatoid arthritis patients (68 percent). Women are more prone to developing the outfit than men. Patients ranged in age from 17 to 86, and all were Dutch.
Each was monitored for the dawn of disease-related physical and mental health disabilities for anywhere from three to five years following their approve diagnosis. Disease activity was also tracked to assess progression. The observed trend: a major two-decade drop in physical disabilities. The researchers also saw a decline in the incidence of worry and depression.
Friday 16 September 2016
A New Therapeutic Vaccine Against Prostate Cancer
A New Therapeutic Vaccine Against Prostate Cancer.
A newly approved beneficial prostate cancer vaccine won the guy wire Wednesday of a Medicare consultive committee, increasing the chances that Medicare will pay for the drug. Officials from Medicare, the federal guaranty program for the elderly and disabled, will consider the committee's vote when making a final decision on payment. Such a finding is expected in several months, the Wall Street Journal reported. The vaccine, called Provenge and made by the Dendreon Corp, costs $93000 per determined and extends survival by about four months on average, according to results from clinical trials.
A swotting published in July in the New England Journal of Medicine found that the vaccine extended the lives of men with metastatic tumors rebellious to orthodox hormonal treatment, compared with no treatment. And the therapy involved less toxicity than chemotherapy.
Provenge is a medicinal (not preventive) vaccine made from the patient's own white blood cells. Once removed from the patient, the cells are treated with the anaesthetize and placed back into the patient. These treated cells then trigger an inoculated response that in turn kills cancer cells, leaving usual cells unharmed.
The vaccine is given intravenously in a three-dose schedule delivered in two-week intervals. "The plan of trying to harness the immune system to fight cancer has been something that tribe have tried to attain for many years; this is one such strategy," study lead researcher Dr Philip Kantoff, a professor of medicament at Harvard Medical School and a medical oncologist at the Dana-Farber Cancer Institute in Boston, told HealthDay.
A newly approved beneficial prostate cancer vaccine won the guy wire Wednesday of a Medicare consultive committee, increasing the chances that Medicare will pay for the drug. Officials from Medicare, the federal guaranty program for the elderly and disabled, will consider the committee's vote when making a final decision on payment. Such a finding is expected in several months, the Wall Street Journal reported. The vaccine, called Provenge and made by the Dendreon Corp, costs $93000 per determined and extends survival by about four months on average, according to results from clinical trials.
A swotting published in July in the New England Journal of Medicine found that the vaccine extended the lives of men with metastatic tumors rebellious to orthodox hormonal treatment, compared with no treatment. And the therapy involved less toxicity than chemotherapy.
Provenge is a medicinal (not preventive) vaccine made from the patient's own white blood cells. Once removed from the patient, the cells are treated with the anaesthetize and placed back into the patient. These treated cells then trigger an inoculated response that in turn kills cancer cells, leaving usual cells unharmed.
The vaccine is given intravenously in a three-dose schedule delivered in two-week intervals. "The plan of trying to harness the immune system to fight cancer has been something that tribe have tried to attain for many years; this is one such strategy," study lead researcher Dr Philip Kantoff, a professor of medicament at Harvard Medical School and a medical oncologist at the Dana-Farber Cancer Institute in Boston, told HealthDay.
Subscribe to:
Posts (Atom)